2Q 2024 Earnings Presentation

2Q24 Earnings Presentation

Reinsurance Group of America, Incorporated

08.01.2024

1

Use of Non-GAAP Financial Measures

Non-GAAP Financial Measures

Reinsurance Group of America, Incorporated (the "Company") discloses certain financial measures that are not determined in accordance with U.S. GAAP. The Company principally uses such non-GAAP financial measures in evaluating performance because the Company believes that such measures, when reviewed in conjunction with relevant U.S. GAAP measures, present a clearer picture of our operating performance and assist the Company in the allocation of its resources. The Company believes that these non-GAAP financial measures provide investors and other third parties with a better understanding of the Company's results of operations, financial statements and the underlying profitability drivers and trends of the Company's businesses by excluding specified items which may not be indicative of the Company's ongoing operating performance and may fluctuate significantly from period to period. These measures should be considered supplementary to the Company's financial results that are presented in accordance with U.S. GAAP and should not be viewed as a substitute for U.S. GAAP measures. Other companies may use similarly titled non-GAAP financial measures that are calculated differently from the way the Company calculates such measures. Consequently, the Company's non-GAAP financial measures may not be comparable to similar measures used by other companies.

The following non-GAAP financial measures are used in this document or in other public disclosures made by the Company from time to time:

1. Adjusted operating income, on apre-taxandafter-taxbasis, and adjusted operating income per diluted share. The Company uses these measures as a basis for analyzing financial results because the Company believes that such measures better reflect the ongoing profitability and underlying trends of the Company's continuing operations. Adjusted operating income is calculated as net income available to the Company's shareholders (or, in the case of pre-tax adjusted operating income, income before income taxes) excluding, as applicable:

• substantially all of the effect of net investment related gains and losses;
• changes in the fair value of certain embedded derivatives;
• changes in the fair value of contracts that provide market risk benefits;
• non-economiclosses at contract inception for direct pension risk transfer single premium business (which are amortized into adjusted operating income within claims and other policy benefits over the estimated lives of the contracts);
• any net gain or loss from discontinued operations;
• the cumulative effect of any accounting changes;
• the impact of certain tax-related items; and
• any other items that the Company believes are not indicative of the Company's ongoing operations

as such items can be volatile and may not reflect the underlying performance of the Company's business. In addition, adjusted operating income per diluted share is calculated as adjusted operating income divided by weighted average diluted shares outstanding. These measures also serve as a basis for establishing target levels and awards under the Company's management incentive programs.

1. Adjusted operating income (on apre-taxandafter-taxbasis), excluding notable items. Notable items are items the Company believes may not be indicative of its ongoing operating performance which are excluded from adjusted operating income to provide investors and other third parties with a better understanding of the Company's results. Such items may be unexpected, unknown when the Company prepares its business plan or otherwise. Notable items presented may include the financial impact of the Company's assumption reviews on business subject to the Financial Accounting Standards Board's Accounting Standards Update No. 2018-12, "Targeted Improvements to the Accounting for Long-Duration Contracts" and related amendments, reflected in future policy benefits remeasurement gains or losses.
2. Adjusted operating revenue. This measure excludes the effects of net realized capital gains and losses, and changes in the fair value of certain embedded derivatives.
3. Shareholders' equity position excluding the impact of accumulated other comprehensive income (loss) ("AOCI"), shareholders' average equity position excluding AOCI, and book value per share excluding the impact of AOCI. The Company believes that these measures provide useful information since such measures excludeAOCI-relateditems that are not permanent and can fluctuate significantly from period to period, and may not reflect the impact of the underlying performance of the Company's businesses on shareholders' equity and book value per share. AOCI primarily relates to changes in interest rates, credit spreads on its investment securities, future policy benefits discount rate measurement gains (losses), market risk benefitsinstrument-specificcredit risk remeasurement gains (losses) and foreign currency fluctuations. The Company also discloses the followingnon-GAAPfinancial measures:
4. • Shareholders' average equity position excluding AOCI and B36, where B36 refers to the cumulative change in fair value of funds withheld embedded derivatives;
   • Shareholders' average equity position excluding AOCI and notable items; and
   • Shareholders' average equity position excluding AOCI, B36 and notable items.
5. Adjusted operating retuon equity. This measure is calculated as adjusted operating income divided by average shareholders' equity excluding AOCI. Adjusted operating retuon equity also serves as a basis for establishing target levels and awards under the Company's management incentive programs. The Company also discloses the following non-GAAP financial measures:
6. • Adjusted operating retuon equity excluding AOCI and B36;
   • Adjusted operating retuon equity excluding AOCI and notable items, which is calculated as adjusted operating income excluding notable items divided by average shareholders' equity excluding notable items and AOCI; and
   • Adjusted operating retuon equity excluding AOCI, B36 and notable items.

Reconciliations of the foregoing non-GAAP financial measures (to the extent disclosed in this document) to the most comparable GAAP financial measures are provided in the Appendix at the end of this document.

3

Second Quarter Key Messages

Strong earnings performance and momentum

• Q2 adjusted operating income of$5.481 per diluted share
• Trailing twelve months adjusted operating ROE of15.3%1
• Strong results in Asia Traditional and Financial Solutions businesses, the U.S. Traditional business, and EMEA Financial Solutions
• Continued positive new business momentum; Traditional premium growth of7.0%; 7.6% on a constant currency basis
• Solid capital deployment of$307 million for the quarter into in-force transactions
• Favorable investment results, with new money rates of6.22%; minimal impairments

41 Please refer to "Reconciliations of Non-GAAP Measures" in the Appendix.

Consolidated Results

51 Please refer to "Reconciliations of Non-GAAP Measures" in the Appendix.

Biometric Experience

Total Company

$ in millions

$100

• Claims experience on our mortality, morbidity and longevity risks.

• Claims experience shown as the difference between actual experience and best estimate expectations. Best estimates are reviewed regularly and can change7 over time.
  3 Pre-tax adjusted operating income.

Favorable biometric experience1 over the previous five quarters

Claims experience not reflected in income will be recognized over the remaining life of the business

• $ in millions.

• Excludes adverse net foreign currency effects of $45 million.

83 The increase is primarily due to a $2.2 billion contribution from single premium pension risk transfer transactions completed in 2024.

Non-Spread Investment Results

• On an amortized cost basis, excluding spread business; average invested assets at amortized cost in Q2 equaled $38.2 billion.

92 Excludes purchases of cash, cash equivalents, U.S. Treasury notes, and purchases made using proceeds from funding agreement-backed notes.

• As of June 30, 2024.

Commercial Mortgage Loans (CML)

111 Based on recorded investment as of June 30, 2024.